Free Trial

Quantinno Capital Management LP Has $7.20 Million Holdings in Corteva, Inc. (NYSE:CTVA)

Corteva logo with Consumer Staples background

Quantinno Capital Management LP raised its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 52.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 126,388 shares of the company's stock after purchasing an additional 43,390 shares during the period. Quantinno Capital Management LP's holdings in Corteva were worth $7,199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its stake in shares of Corteva by 6.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after buying an additional 288,885 shares during the period. Wedmont Private Capital raised its stake in Corteva by 16.5% in the 4th quarter. Wedmont Private Capital now owns 4,708 shares of the company's stock valued at $269,000 after purchasing an additional 668 shares during the last quarter. SeaCrest Wealth Management LLC raised its stake in Corteva by 4.0% in the 4th quarter. SeaCrest Wealth Management LLC now owns 6,288 shares of the company's stock valued at $358,000 after purchasing an additional 244 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Corteva by 755.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock valued at $31,486,000 after purchasing an additional 488,181 shares during the last quarter. Finally, Burney Co. grew its holdings in Corteva by 6.3% in the 4th quarter. Burney Co. now owns 4,505 shares of the company's stock valued at $257,000 after buying an additional 266 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CTVA. Morgan Stanley increased their price target on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Citigroup lifted their price target on Corteva from $75.00 to $78.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. The Goldman Sachs Group started coverage on Corteva in a research note on Thursday, March 13th. They issued a "buy" rating and a $71.00 target price on the stock. UBS Group lifted their price target on Corteva from $74.00 to $76.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Finally, Barclays lifted their price target on Corteva from $64.00 to $70.00 and gave the company an "equal weight" rating in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $70.50.

Check Out Our Latest Stock Report on Corteva

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.14% of the company's stock.

Corteva Stock Up 0.5%

NYSE CTVA traded up $0.32 during trading on Tuesday, hitting $69.13. 3,265,672 shares of the company traded hands, compared to its average volume of 3,300,169. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $69.28. The business has a fifty day simple moving average of $61.81 and a 200 day simple moving average of $61.04. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $47.16 billion, a P/E ratio of 53.59, a PEG ratio of 1.68 and a beta of 0.72.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $0.88 by $0.25. The business had revenue of $4.42 billion for the quarter, compared to analyst estimates of $4.56 billion. Corteva had a return on equity of 7.19% and a net margin of 5.36%. The firm's revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.89 earnings per share. As a group, sell-side analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date is Monday, June 2nd. Corteva's payout ratio is 41.46%.

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Featured Articles

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines